Diamox
Diamox Price range: $ 60,00 through $ 144,00
Back to products
Diarex
Diarex Price range: $ 54,00 through $ 236,00

Diane 35

Price range: $ 16,00 through $ 46,00

Diane-35 is a specialized hormonal treatment designed to manage severe acne and androgen-related skin conditions in women. This medication combines cyproterone acetate and ethinylestradiol to effectively regulate the hormonal imbalances that contribute to persistent skin imperfections. It is particularly indicated for treating inflammatory acne that has not responded to conventional antibiotic therapies or topical treatments. In addition to clearing the complexion, Diane-35 helps reduce excessive facial and body hair growth caused by androgenic activity. By targeting the underlying causes of these symptoms, this formula promotes healthier skin and improved overall confidence.

SKU: Diane 35 Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Diane 35 belongs to a combination group of hormonal medications containing an anti-androgen (cyproterone acetate) and an estrogen (ethinylestradiol). It is primarily formulated to target severe androgen-dependent skin conditions, such as resistant acne and moderate hirsutism in female patients of reproductive age.

While widely prescribed internationally, this specific formulation is dispensed in accordance with applicable federal and state regulations. Understanding both its therapeutic benefits and its safety profile helps ensure informed decisions under proper healthcare oversight.

Drug name Diane 35
Active ingredient (INN) Cyproterone acetate / Ethinylestradiol
Dosage form Oral tablet
Route of administration Oral
Primary purpose Androgen-dependent acne and hirsutism management
Prescription status Dispensed in accordance with applicable federal and state regulations

How the drug works

Diane 35 combines two distinct active components: cyproterone acetate (2 mg) and ethinylestradiol (0.035 mg). Cyproterone acetate acts as an anti-androgen by blocking androgen receptors located in the skin, sebaceous glands, and hair follicles, while simultaneously inhibiting the luteinizing hormone (LH) signal from the pituitary gland. Ethinylestradiol, a synthetic estrogen, increases sex hormone-binding globulin (SHBG) synthesis in the liver. This rise in SHBG binds circulating free testosterone, markedly lowering active androgen levels in the blood. Together, these mechanisms reduce sebum production, clear blocked pores, and slow androgen-stimulated terminal hair growth.

What it’s used for

Diane 35 is indicated for the treatment of moderate to severe androgen-sensitive acne, often accompanied by seborrhea, that has failed to respond adequately to topical therapies or systemic antibiotics. Additionally, it is prescribed for the management of mild to moderate hirsutism in women of childbearing potential. Because of its hormonal composition, Diane 35 also functions as an effective oral contraceptive; however, it should not be prescribed solely for birth control in the absence of androgenic skin disorders. Once the underlying skin condition has completely resolved, healthcare providers typically recommend transitioning to a standard oral contraceptive if ongoing pregnancy prevention is desired.

Dosing schedule

Treatment follows a strict 28-day cyclic schedule. Patients take one tablet daily at approximately the same time for 21 consecutive days, followed by a 7-day pill-free interval. Withdrawal bleeding usually begins two to three days after taking the last active tablet. The next 21-day pack is started precisely on the eighth day, regardless of whether bleeding has stopped. For initial therapy, the first tablet is taken on day one of the natural menstrual cycle. Tablets should be swallowed whole with water. Consistent daily administration is critical to maintain both therapeutic efficacy and reliable contraceptive protection.

What happens in the body

Following oral administration, cyproterone acetate is completely absorbed, achieving peak serum concentrations within 1.6 hours. It binds almost exclusively to plasma albumin, with an elimination half-life ranging from 38 to 44 hours. Ethinylestradiol is also rapidly absorbed, reaching maximum plasma concentrations in 1.6 to 1.8 hours, but undergoes extensive first-pass hepatic metabolism, resulting in an absolute bioavailability of approximately 45%. Ethinylestradiol binds heavily to serum albumin and exhibits an elimination half-life of roughly 24 hours. Both substances are excreted as metabolites in urine and bile, with cyproterone elimination occurring largely through biliary pathways.

Compatibility with other medicines

Co-administration of Diane 35 with hepatic enzyme inducers can significantly lower plasma steroid levels and compromise therapeutic efficacy. Drugs such as rifampin, carbamazepine, phenytoin, phenobarbital, topiramate, and St. John’s wort accelerate the metabolic clearance of ethinylestradiol and cyproterone. Concomitant use with certain HIV protease inhibitors or hepatitis C virus combination regimens (e.g., ombitasvir/paritaprevir/ritonavir) may alter clearance or increase liver enzyme toxicity. Furthermore, broad-spectrum antibiotics may temporarily disrupt enterohepatic circulation of estrogens, reducing systemic exposure. Patients using these medications concurrently may require barrier contraception or alternative medical strategies.

What side effects may occur

On one hand, many patients tolerate treatment without major complications; on the other hand, minor and serious adverse events are documented. Commonly reported side effects include nausea, abdominal pain, mild weight fluctuations, headache, breast tenderness, and mood changes. Some individuals experience breakthrough bleeding or spotting during the first few treatment cycles. More serious, though less frequent, adverse events involve cardiovascular complications such as deep vein thrombosis (DVT), pulmonary embolism (PE), myocardial infarction, and stroke. The risk of venous thromboembolism is elevated compared to non-users of hormonal therapies. Other potential severe reactions include hepatic adenomas, elevated blood pressure, and cholelithiasis. Patients who develop severe unilateral leg swelling, sudden shortness of breath, severe chest pain, or visual disturbances should seek immediate emergency medical evaluation.

Important precautions

Diane 35 carries an elevated risk of venous thromboembolism (VTE) compared to low-dose combined oral contraceptives containing levonorgestrel. It is contraindicated in patients with a history of deep vein thrombosis, pulmonary embolism, active or past arterial thromboembolic disease, severe liver disease, estrogen-dependent malignancies, or unexplained vaginal bleeding. Cigarette smoking markedly increases the risk of serious cardiovascular adverse effects, particularly in women over 35 years of age. Treatment should be discontinued prior to major elective surgeries or prolonged immobilization to reduce thromboembolic hazards. Regular blood pressure screening and clinical breast evaluations are recommended throughout therapy.

Food and alcohol interactions

Food does not significantly alter the overall bioavailability of cyproterone acetate or ethinylestradiol, so tablets may be taken with or without food. Taking the tablet with meals or at bedtime may reduce early treatment nausea. Grapefruit juice inhibits CYP3A4 enzymes and may modestly increase circulating steroid concentrations. Moderate alcohol consumption does not directly interfere with the pharmacology of Diane 35; however, excessive alcohol intake can increase liver strain and may impair the consistency of daily medication adherence.

What you may notice early on

During the initial weeks of treatment, subtle physical adjustments are common. Reductions in skin oiliness (seborrhea) typically become noticeable within three to four weeks. Improvements in inflammatory acne lesions generally require two to three full treatment cycles (8 to 12 weeks) to become evident. Reduction of excess facial hair growth (hirsutism) develops more slowly, often taking several months of continuous therapy due to the long lifecycle of hair follicles. Transient side effects like mild breast enlargement or nausea usually diminish after the first two cycles.

If you skip a dose

If a tablet is missed and remembered within 12 hours of the usual time, it should be taken immediately, and subsequent tablets taken at the regular time. If more than 12 hours have elapsed, contraceptive protection may be compromised. In such instances, the missed tablet should still be taken as soon as realized, even if it means taking two tablets on the same day. Additional non-hormonal barrier contraception (such as condoms) must be used for the next seven consecutive days while continuing regular pill intake.

Special populations

Diane 35 is strictly contraindicated during pregnancy; active pregnancy must be ruled out before initiating therapy. Cyproterone acetate and ethinylestradiol pass into breast milk, reducing milk production and altering composition; thus, use is not recommended during lactation. The safety and efficacy of Diane 35 have not been established in pediatric populations prior to menarche. Use in postmenopausal women is not indicated. Patients with impaired renal function have not been formally studied, though hepatic impairment significantly delays metabolic clearance, making severe liver disease an absolute contraindication.

Common questions

How long can I remain on Diane 35?

Healthcare guidance generally limits the duration of Diane 35 to the time necessary to resolve the underlying acne or hirsutism. Once skin symptoms show full remission, treatment should be re-evaluated, and transitioning to a standard oral contraceptive or alternative therapy is typically advised to limit long-term thromboembolic risks.

Does Diane 35 cause weight gain?

On one hand, fluid retention caused by estrogenic activity may lead to minor transient weight shifts during early treatment. On the other hand, clinical studies show no consistent long-term increase in body fat directly attributed to cyproterone acetate and ethinylestradiol combination therapy.

What should I do if I vomit after taking a tablet?

If severe vomiting or diarrhea occurs within three to four hours after taking an active pill, absorption may be incomplete. This situation should be managed as a missed dose. Take another tablet from a backup pack as soon as possible and follow missed-pill protocols if gastrointestinal symptoms persist.

Can I take Diane 35 to delay my period?

Modifying the cycle by skipping the 7-day break to delay withdrawal bleeding should only be done under explicit instruction from a healthcare provider. Unscheduled bleeding or spotting is more likely when consecutive packs are taken without interruption.

Is it safe to drive after taking Diane 35?

Diane 35 has no known adverse effects on the ability to drive or operate machinery. However, if you experience rare nervous system symptoms such as severe migraines or dizziness, avoid driving until symptoms fully resolve.

In accordance with FDA standards and federal guidance.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

0.035 mg + 2 mg

Package

21 tabs

,

42 tabs

,

84 tabs

Ενεργός Ουσία

,